Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Author affiliations: University of Massachusetts–Amherst, Amherst, Massachusetts USA (G. Xu, C.-Y. Luo, F. Ribbe, P. Pearson, S.M. Rich); L2 Diagnostics, New Haven, Connecticut, USA (M. Ledizet)

Borrelia miyamotoi, a relapsing fever group spirochete (1), was first isolated from Ixodes persulcatus ticks in Japan in 1995 (2) and later detected in Ixodes ticks in the United States and Europe (35). Although B. miyamotoi bacteria have been mainly detected in I. ricinus species complex ticks that transmit B. burgdorferi worldwide, the vector specificity needs further study because investigators have found B. miyamotoi in multiple tick species (6). B. miyamotoi has 3 geographically distinct genotypes: Asian, European, and American. In the United States, B. miyamotoi bacteria have been found in field-collected I. scapularis ticks in the northeastern and northern midwestern regions, where the average infection rate is 1.9% (7). However, an expanded geographic study of the prevalence of B. miyamotoi in human-biting ticks, its genotypes, and concurrent infections with other tickborne pathogens is warranted.

Human-biting ticks were submitted to the public tick testing program at the University of Massachusetts (Amherst, Massachusetts, USA) during May 2013–December 2019. We extracted DNA from individual ticks using the Epicenter Master Complete DNA and RNA Purification Kits (Lucigen, https://www.lucigen.com). We performed a species-specific quantitative PCR (qPCR) for differentiation of I. scapularis and I. pacificus ticks (8). To detect Borrelia bacteria, we first applied a genus-specific detection assay, followed by specific qPCR assays for B. burgdorferi sensu lato and B. miyamotoi. We detected the tickborne pathogens Anaplasma phagocytophilum, Babesia microti, B. mayonii, and Ehrlichia muris–like agent (EMLA) by a multiplex qPCR assay targeting different genes. We used a qPCR assay targeting tick 16S mtDNA gene as an internal control (8). We sequenced 3 partial gene fragments, 16S rDNA (16S) (9), flagellin (fla) (6), and glycerophosphodiester phosphodiesterase (glpQ) (6), for B. miyamotoi samples that were positive by qPCR.

We received and tested 39,198 ticks found on humans for B. miyamotoi during May 2013– December 2019. Of those, 38,855 (99.12%) ticks originated from the continental United States, comprising 18 tick species (Table). Although Ixodes ticks are the main vectors for B. miyamotoi, we did not detect B. miyamotoi DNA in I. affinis, I. angustus, I. cookei, I. dentatus, I. marxi. I. muris, or I. spinipalpis ticks. We detected B. miyamotoi in I. pacificus (14/1,497, 0.94%) and I. scapularis (594/34,621, 1.72%) ticks.


Borrelia miyamotoi positivity rates in human-biting Ixodes scapularis and I. pacificus ticks, United States, 2013–2019. Gray shading indicates states in which B.miyamotoi was detected in human-biting ticks.

Figure. Borrelia miyamotoi positivity rates in human-biting Ixodes scapularis and I. pacificus ticks, United States, 2013–2019. Gray shading indicates states in which B.miyamotoiwas detected…

B. miyamotoi was found in 19 states; infection rates were 0.5%–3.2% (Figure). In the western United States, B. miyamotoi was found in I. pacificus ticks in Oregon and California (14/1,497, 0.94%). Although I. scapularis ticks are distributed across the eastern United States, no B. miyamotoi–positive ticks were detected south of Virginia. B. miyamotoi–positive ticks were concentrated in the Northeast and upper Midwest (594 of 34,621, 1.72%) (Figure). Lyme disease remains the principal public health concern; the causative agent, B. burgdorferi (11,287/34,621; 32.60%, 95% CI 32.1%–33.1%), was 19 times more prevalent than B. miyamotoi (594/34,621, 1.72%) in I. scapularis ticks.

On average, prevalence of B. miyamotoi infection in I. scapularis ticks (1.72%, 95% CI 1.58%–1.86%) was higher than in I. pacificus ticks (0.94%, 95% CI 0.51%–1.56%). The prevalence of B. miyamotoi in I. pacificus ticks was 1.00% (95% CI 0.53%–1.7%) in adults (13/1,300), 0.53% (95% CI 0.01%–2.9%) in nymphs (1/190), and 0.00% (95% CI 0%–40.1%) in larvae (0/7). The prevalence of B. miyamotoi in I. scapularis ticks was 1.80% (95% CI 1.64%–1.97%) in adults (456/25,376), 1.54% (95% CI 1.29−1.83%) in nymphs (133/8,615), and 0.79% (95% CI 0.26%–1.84%) in larvae (5/630).

Of 594 B. miyamotoi–positive I. scapularis ticks, 351 (59.09%) had concurrent infections. We found 293 (49.33%) I. scapularis ticks had a dual infection with B. miyamotoi: 220 (37.04%) were also infected with B. burgdorferi s.l., 43 (7.24%) with A. phagocytophilum, and 30 (5.05%) with B. microti. We further found 52 (8.75%) had a triple infection with B. miyamotoi: 23 (3.87%) were also infected with B. burgdorferi s.l. and A. phagocytophilum, 22 (3.70%) with B. burgdorferi s.l. and B. microti, and 7 (1.18%) with A. phagocytophilum and B. microti. Six (1.01%) of the B. miyamotoi–positive ticks had a quadruple infection with B. miyamotoi, B. burgdorferi s.l., A. phagocytophilum, and B. microti. No ticks with B. mayonii or EMLA were additionally infected with B. miyamotoi.

Multilocus sequence typing of the 16S, fla, and glpQ genes revealed 2 distinct B. miyamotoi genotypes separated by their tick vectors, I. scapularis ticks in the Northeast and upper Midwest and I. pacificus ticks in the West (Appendix). Whereas the 16S gene sequences were identical among all isolates, variable sites were found among fla and glpQ nucleotide sequences. Among 14 I. pacificus tick–borne B. miyamotoi isolates, all fla and glpQ sequences were identical. A previously reported A/G substitution in B. miyamotoi fla sequences from I. pacificus ticks (5,9) was outside of our sequenced fla fragment (Appendix). The genetic identity between the 2 tick species–specific genotypes was 0.996 for fla and 0.986 for glpQ. Unlike heterogeneous B. burgdorferi populations, B. miyamotoi appears to be very homogeneous within its respective tick vectors.

Dr. Xu is a research professor in the department of microbiology, University of Massachusetts–Amherst. His research interests include ticks and tickborne diseases.


The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.

Source : CDC Emerging Infectious Diseases Journal

NBS Bank Your Caring Bank